IeDEA

IeDEA
Name	International epidemiology Databases to Evaluate AIDS
Formation	2006
Type	Research consortium
Region served	Global
Leader title	Executive Secretariat

IeDEA

IeDEA is a global consortium for observational research focused on HIV/AIDS clinical outcomes, treatment, and epidemiology. It aggregates cohort data from multiple regions to inform policy and practice related to antiretroviral therapy, pediatric HIV, and pregnancy-associated infections. The consortium engages with national programmes, international agencies, and academic centers to generate evidence for stakeholders including the World Health Organization, UNAIDS, and national ministries.

Overview

IeDEA assembles longitudinal patient-level data from observational cohorts drawn from networks of clinics, hospitals, and research institutions to address questions about HIV care delivery, treatment effectiveness, and co-infections such as tuberculosis and hepatitis C. The consortium supports analyses relevant to guideline-setting bodies like the U.S. Centers for Disease Control and Prevention, the European Medicines Agency, and regional public health authorities. IeDEA data inform clinical practice, modelling studies affiliated with Imperial College London, and programmatic evaluation by organizations such as the Bill & Melinda Gates Foundation and the National Institutes of Health.

History and Development

IeDEA was established to harmonize observational HIV cohort data across geographic regions and to provide timely evidence during rapidly evolving policy landscapes, including the shift to universal antiretroviral therapy and treat-all strategies endorsed by the World Health Organization. Early formative work built on legacy cohorts affiliated with institutions such as Johns Hopkins University, University of Cape Town, Makerere University, and McGill University. Funding and coordination involved stakeholders including the National Institute of Allergy and Infectious Diseases and partnerships with regional research networks like the East African Microbiology Research Network. Over time, IeDEA expanded to include pediatric, adult, and perinatal cohorts, linking outcomes to initiatives led by the President's Emergency Plan for AIDS Relief and evaluations used by the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Structure and Participating Regions

IeDEA is organized into regionally based data centers that reflect epidemiologic diversity: for example, networks representing Sub-Saharan Africa, Asia-Pacific, Caribbean, Latin America, and North America. Regional hubs often align with academic partners such as University of the Western Cape, Khon Kaen University, Universidad Nacional de Colombia, and Vanderbilt University Medical Center. Governance includes steering committees, data harmonization working groups, and ethics review processes involving institutional review boards at sites like Mbarara University of Science and Technology and Harvard T.H. Chan School of Public Health. Participating clinics range from tertiary hospitals such as Groote Schuur Hospital to primary-care networks supported by organizations like Médecins Sans Frontières.

Research Activities and Key Findings

IeDEA conducts cohort studies, pharmacoepidemiology, survival analyses, and implementation science focusing on topics such as treatment durability, viral suppression, regimen switching, and drug resistance. Key findings have addressed maternal-child transmission trends relevant to guidance from UNICEF, the impact of early antiretroviral initiation informed by trials connected to groups like INSIGHT and START, and outcomes among marginalized populations highlighted by advocacy groups such as amfAR. Analyses have quantified mortality patterns similar to reports from The Lancet HIV and informed modelling efforts by teams at University College London and Johns Hopkins Bloomberg School of Public Health. Studies have examined coinfection burdens with Mycobacterium tuberculosis and outcomes with antiretroviral regimens evaluated by investigators at Columbia University and Stanford University.

Data Management and Governance

IeDEA emphasizes standardized data dictionaries, common data models, and secure data transfer procedures aligned with best practices promoted by organizations like International Committee of Medical Journal Editors and data repositories such as Dryad. Data governance frameworks incorporate consent models, data-sharing agreements, and privacy safeguards adhering to regulations referenced by bodies like the European Union and the U.S. Department of Health and Human Services. Quality assurance involves site-level audits, data cleaning coordinated with centers such as Kaiser Permanente and statistical programming conducted in collaboration with groups at Fred Hutchinson Cancer Research Center.

Collaborations and Impact

IeDEA collaborates with global partners including the World Health Organization, UNAIDS, national ministries of health, academic centers such as University of California, San Francisco, and funders including the National Institutes of Health and the Bill & Melinda Gates Foundation. Outputs have influenced WHO guidelines, national treatment protocols in countries like South Africa, Uganda, and Brazil, and contributed data to large meta-analyses alongside cohorts from COHERE and consortia like HIV Cohorts Collaborative. The consortium supports capacity building through training with universities such as Makerere University and University of Nairobi and contributes to surveillance used by agencies like the Pan American Health Organization.

Challenges and Future Directions

IeDEA faces challenges common to multi-national consortia: harmonizing heterogeneous electronic medical records used by sites like King Edward VIII Hospital and rural clinics, addressing missing data, and ensuring equitable authorship and capacity strengthening across partners including University of Zambia and Universidad de la República (Uruguay). Future priorities include integrating novel data streams (pharmacovigilance, genomics) in partnership with institutions such as Broad Institute and Wellcome Sanger Institute, strengthening implementation science with collaborators like London School of Hygiene & Tropical Medicine, and enhancing policy translation for stakeholders including GAVI, the Vaccine Alliance and national health ministries.

Category:HIV/AIDS research networks